methyl 2-(4-chloro-6-methoxypyrimidin-5-yl)acetate

Catalog No. :
ACHUTX021
CAS No. :
171096-34-7
Molecular Formula :
C8H9ClN2O3
Molecular Weight :
216.62

IUPAC Name:methyl 2-(4-chloro-6-methoxypyrimidin-5-yl)acetate

methyl 2-(4-chloro-6-methoxypyrimidin-5-yl)acetate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$492.00Login to see priceInquiryInquiry
1g95%$1538.00Login to see priceInquiryInquiry
5g95%$4616.00Login to see priceInquiryInquiry
10g95%$6455.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Namemethyl 2-(4-chloro-6-methoxypyrimidin-5-yl)acetate
IUPAC Namemethyl 2-(4-chloro-6-methoxypyrimidin-5-yl)acetate
Molecular FormulaC8H9ClN2O3
Molecular Weight216.62
SMILESO=C(OC)CC1=C(OC)N=CN=C1Cl
InChI KeyLQRCZEMNPQCPCO-UHFFFAOYSA-N
SynonymMethyl 2-(4-chloro-6-methoxypyrimidin-5-yl)acetate;5-Pyrimidineacetic acid, 4-chloro-6-methoxy-, methyl ester
CAS No.171096-34-7

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACHUTX021 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACEGTO725 route compound structure diagram
    ACEGTO725171096-33-6 In Stock
  2. Plus
  3. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9 In Stock
  4. Then
  5. ACHUTX021 route product structure diagram
    ACHUTX021171096-34-7
Inquiry

2. ACHUTX021 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9 In Stock
  2. Plus
  3. ACEGTO725 route compound structure diagram
    ACEGTO725171096-33-6 In Stock
  4. Then
  5. ACHUTX021 route product structure diagram
    ACHUTX021171096-34-7
Inquiry

Comments (0)